Cargando...
Infection risk in autoimmune hematological disorders with low‐dose rituximab treatment
BACKGROUND: Rituximab has been widely used in many autoimmune diseases. AIM: To evaluate the infection risk of rituximab in autoimmune hematological disorders. METHODS: Retrospectively studied and compared the clinical data of 89 patients in our hospital who used low‐dose rituximab (group R) or puls...
Guardado en:
| Publicado en: | J Clin Lab Anal |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7595891/ https://ncbi.nlm.nih.gov/pubmed/32794271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcla.23455 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|